Drugs for Leukemia, Lymphoma and Myeloma

The information is about a portion of the more current, directed medication medicines for blood tumour that are beginning to be utilized or have been as of late affirmed for use in individuals with Blood Cancer. The list includes generic and brand names. This page likewise records basic medication mixes utilized as a part of leukemia. The individual medications in the mixes are FDA-endorsed. List of cancer medicine approved by the nourishment and drugs Administration for non-Hodgkin lymphoma. Chemotherapy is the utilization of medicines to crush or control malignancy cells. These medications can be taken by mouth or given in a vein or a muscle. They enter the circulation system and achieve all regions of the body

Leukemia Drugs:

  • Arranon (Nelarabine)
  • Asparaginase Erwinia chrysanthemi
  • Hyper-CVAD

Lymphoma Drugs:

  • Doxorubicin
  • Bleomycin
  • Vinblastine

Myeloma Drugs:

  • Melphalan
  • Vincristine (Oncovin)
  • Cyclophosphamide (Cytoxan)

 

  • Arranon (Nelarabine)
  • Asparaginase Erwinia chrysanthemi
  • Doxorubicin, Bleomycin, Vinblastine,Dacarbazine
  • Melphalan Vincristine (Oncovin),Cyclophosphamide (Cytoxan), Etoposide (VP-16)

Related Conference of Drugs for Leukemia, Lymphoma and Myeloma

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Drugs for Leukemia, Lymphoma and Myeloma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in